Skip to content

Auditory Verbal Hallucinations in Schizophrenia

Electromyography Study of Lip Muscles During Auditory Verbal Hallucinations Without Subvocalization in Patients With Schizophrenia

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01886417
Acronym
HAV
Enrollment
40
Registered
2013-06-25
Start date
2009-10-31
Completion date
2015-03-31
Last updated
2015-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia

Brief summary

Auditory verbal hallucinations (AVHs) are speech perceptions in the absence of a relevant external stimulation. Some accounts of AVHs claim that a deficit in inner speech monitoring would cause the verbal thoughts of the patient to be perceived as external voices resulting in AVHs. In order to examine whether AVHs correspond to self-generated inner speech, the present study aims at collecting speech muscle activity during covert AVHs (without articulation), overt speech and rest. Surface electromyography (sEMG) is used on schizophrenia patients and control subjects to detect any speech muscle activity during AVH.

Interventions

None listed

Sponsors

GIPSA-LAB
CollaboratorOTHER
University Hospital, Grenoble
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

Healthy controls: * must be more than 18 years and less than 60 years old * pre-inclusion medical examination * must have signed consent form * must be able to read stimuli on a screen Schizophrenia patients: * must be more than 18 years and less than 60 years old * pre-inclusion medical examination * must have signed consent form * must be able to read stimuli on a screen * diagnosed with a schizophrenia disorder according to DSM-IV TR (diagnostic and statistical of mental disorders) (PANSS item P3 greater than 4) * prior evaluation of the secondary effects of any medication via Barnes and AIMS scales * affiliated with the French social security * if under guardianship, must have additional consent form signed by guardian

Exclusion criteria

Healthy controls: * if aged less than 18 years or more than 60 years * diagnosed with any psychiatric disorder * with any language disorder (aphasia, SLI, dysarthria, stuttering, etc.) * with auditory impairment * pregnant, parturient, breast-feeding Schizophrenia patients: * if aged less than 18 years or more than 60 years * significant secondary effects of antipsychotic medication, measured with the Barnes and AIMS scales * with a neurodegenerative disease * with any language disorder (aphasia, SLI, dysarthria, stuttering, etc.) * with auditory impairment * pregnant, parturient, breast-feeding

Design outcomes

Primary

MeasureTime frame
Labial EMG activity during auditory verbal hallucinationup to 3 years

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026